For research use only. We do not sell to patients.
Research lipid catalog

Ionizable Lipid Products

Explore 848 lipid and RNA delivery products. Search the full catalog or browse by research category.

Search covers product name, catalog number, synonyms, available CAS numbers and categories. Spaces, hyphens and common punctuation are ignored. Duplicate legacy records are consolidated under one canonical product result.

3666 products · Showing 1041–1060 · 20 per page
DC Chemicals lipid expertise

Built for ionizable-lipid discovery and RNA delivery research

DC Chemicals supports formulation and delivery research with a broad, searchable portfolio of cationic and ionizable lipids. The current directory brings together 848 unique research-use products, with product specifications, pricing, chemical structures and literature-linked formulation data added as each record is verified.

Our experience spans complex lipid synthesis, purification, analytical release and process development. For custom molecules or larger-scale requirements, our team can discuss route development, technical specifications and scale-up options for the intended research workflow.

Learn about cationic and ionizable lipids →
848unique products in the current searchable directory
Evidence-awareliterature modules appear only after source review
Research supportformulation context, handling guidance and calculators
Proprietary innovation · Co-development · GMP

From proprietary lipid design to GMP-grade custom synthesis

DC Chemicals has independently developed ionizable-lipid structures supported by company-owned intellectual property, and selected proprietary lipid programs have advanced to GMP-stage development.

We welcome joint development with customers—from molecular design and lipid synthesis through route and process development. We can also support custom synthesis of GMP-grade ionizable lipids to agreed technical specifications and quality requirements.

Discuss a co-development project →
Proprietary ionizable-lipid structuresCollaborative molecular designCustom lipid synthesisProcess development and scale-upGMP-grade project support

Cat. No.Product NameField of ApplicationChemical Structure
100 mg USD 400 · 250 mg USD 700 · 1 g USD 1,500 · 10 mM * 1 mL in DMSO USD 150

ABT-751(E 7010) is a novel bioavailable tubulin-binding and antimitotic sulfonamide agent with IC50 of about 1.5 and 3.4 μM in neuroblastoma and non-neuroblastoma cell lines, respectively.

ABT-751(E 7010) chemical structure
GSK650394Featured
100 mg USD 500 · 250 mg USD 900 · 1 g USD 1,800 · 10 mM * 1 mL in DMSO USD 220

GSK 650394 is a novel SGK inhibitor with IC50 of 62 nM and 103 nM for SGK1 and SGK2 in the SPA assay respectively.

GSK650394 chemical structure
WEHI-345Featured
100 mg USD 550 · 250 mg USD 950 · 1 g USD 1,900 · 10 mM * 1 mL in DMSO USD 220

WEHI-345 is a potent and selective inhibitor of RIPK2, with IC50 of 0.13 μM.

WEHI-345 chemical structure
100 mg USD 250 · 250 mg USD 500 · 1 g USD 1,000 · 10 mM * 1 mL in DMSO USD 150

Aliskiren hemifumarate(CGP 60536) is a direct renin inhibitor with IC50 of 1.5 nM.

Aliskiren Hemifumarate chemical structure
1 g USD 1,200 · 100 mg USD 350 · 250 mg USD 600 · 10 mM * 1 mL in DMSO USD 150

AG-1024 (Tyrphostin) inhibits IGF-1R autophosphorylation with IC50 of 7 μM, less potent to IR with IC50 of 57 μM.

AG-1024 (Tyrphostin) chemical structure
100 mg USD 450 · 250 mg USD 800 · 1 g USD 1,600 · 10 mM * 1 mL in DMSO USD 220

TM5275 sodium is a plasminogen activator inhibitor (PAI-1) with an IC50 of 6.95 μM.

TM5275 sodium salt chemical structure
SBC-110736Featured
100 mg USD 500 · 250 mg USD 900 · 1 g USD 1,700 · 10 mM * 1 mL in DMSO USD 220

SBC-110736 is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor extracted from patent WO2014150395A1, Figure 1.

SBC-110736 chemical structure
CZC-25146Featured
100 mg USD 550 · 250 mg USD 1,000 · 1 g USD 1,900 · 10 mM * 1 mL in DMSO USD 220

CZC-25146 is a potent, selective and metabolically stable LRRK2 inhibitor with IC50 of 4.76 nM/6.87 nM for wild type LRRK2 and G2019S LRRK2 respectively.

CZC-25146 chemical structure
B-Raf IN 1Featured
100 mg USD 375 · 250 mg USD 750 · 1 g USD 1,500 · 10 mM * 1 mL in DMSO USD 150

B-Raf IN 1 is a potent and selective B-Raf kinase inhibitor with an IC50 of 24 nM.

B-Raf IN 1 chemical structure
NicaravenFeatured
100 mg USD 420 · 250 mg USD 825 · 1 g USD 1,500 · 10 mM * 1 mL in DMSO USD 220

Nicaraven is a novel chemically synthesized hydroxyl radical-specific scavenger.

Nicaraven chemical structure
ApoptozoleFeatured
100 mg USD 450 · 250 mg USD 700 · 1 g USD 1,450 · 10 mM * 1 mL in DMSO USD 220

Apoptozole is an inhibitor of the ATPase domain of Hsc70 and Hsp70, with Kds of 0.21 and 0.14 μM, respectively, and can induce apoptosis.

Apoptozole chemical structure
100 mg USD 400 · 250 mg USD 700 · 1 g USD 1,300 · 10 mM * 1 mL in DMSO USD 150

AG 555 is an EGFR tyrosine kinase inhibitor.

Tyrphostin AG-555 chemical structure
100 mg USD 800 · 250 mg USD 1,500 · 1 g USD 2,900 · 10 mM * 1 mL in DMSO USD 220

CGS 21680 Hydrochloride is a selective adenosine A2A receptor agonist with a Ki of 27 nM.

CGS 21680 hydrochloride chemical structure
AZD-1208Featured
100 mg USD 350 · 250 mg USD 600 · 1 g USD 1,300 · 10 mM * 1 mL in DMSO USD 150

AZD1208 is a novel, orally bioavailable, highly selective PIM kinases inhibitor.

AZD-1208 chemical structure
1 g USD 1,300 · 100 mg USD 400 · 250 mg USD 650 · 10 mM * 1 mL in DMSO USD 150

Pimasertib (AS703026) is a highly selective, potent, ATP non-competitive allosteric inhibitor of MEK1/2, used for cancer treatment.

AS703026(Pimasertib) chemical structure
CID 797718Featured
100 mg USD 448 · 250 mg USD 880 · 1 g USD 1,600 · 10 mM * 1 mL in DMSO USD 220

CID-797718 is a compound with unknown details. For the detailed information of CID 797718, the solubility of CID 797718 in water, the solubility of CID 797718 in DMSO, the solubility of CID 797718 in PBS buffer, the animal experiment (test) of CID 797718, the cell expriment (test) of CID 797718, the in vivo, in vitro and clinical trial test of CID 797718, the EC50, IC50,and affinity,of CID 797718, Please contact DC Chemicals.

CID 797718 chemical structure
100 mg USD 550 · 250 mg USD 850 · 1 g USD 1,800 · 10 mM * 1 mL in DMSO USD 220

CID5721353 is an inhibitor of BCL6 with an IC50 value of 212 μM, which corresponds to a Ki of 147 μM.

BCL6 inhibitor(CID5721353) chemical structure
100 mg USD 500 · 250 mg USD 900 · 1 g USD 1,800 · 10 mM * 1 mL in DMSO USD 220

FGF-401 is an inhibitor of FGFR4 extracted from patent WO2015059668A1, compound example 83; has an IC50 of 1.9 nM.

FGF401( Roblitinib) chemical structure
NS638Featured
100 mg USD 450 · 250 mg USD 800 · 1 g USD 1,500 · 10 mM * 1 mL in DMSO USD 220

NS-638 is a small nonpeptide molecule with Ca2+-channel blocking properties. K+-stimulated intracellular Ca2+-elevation is blocked with an IC50 value of 3.4 μM.

NS638 chemical structure
10074-G5Featured
100 mg USD 320 · 250 mg USD 600 · 1 g USD 1,200 · 10 mM * 1 mL in DMSO USD 150

10074-G5 is an inhibitor of c-Myc-Max dimerization with an IC50 of 146 μM.

10074-G5 chemical structure

Page 53 of 184 · Browse all 3666 products

Jump to a product page